192
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Preparation, characterization and in vitro-targeted delivery of novel Apolipoprotein E-based nanoparticles to C6 glioma with controlled size and loading efficiency

, &
Pages 348-358 | Received 06 Jan 2015, Accepted 27 Jul 2015, Published online: 24 Aug 2015
 

Abstract

Apolipoprotein E (APOE) with its extraordinary features is readily assembled with hydrophobic compounds via its compact hydrophobic units (CHUs). These assemblies can then be converted to stable particles by protein–protein interactions via coiled coil regions (CCRs) which exist in APOE structure. Applying these features of APOE, we prepared novel nanoparticles called NAPOE, using no cross-linker. Vitamin D3 – a hydrophobic antitumor model – was loaded within the nanoparticles (NPs). The NPs were mostly spherical with the mean diameter and zeta potential of 94.39 ± 5.71 nm and −20 ± 0.3 mV, respectively. The molar ratio of VD3/APOE in NPs was 37.2 ± 0.61. The NPs targeted C6 glioma cells in vitro via over-expressed LDLRs. The efficiency of the NPs uptake to malignant C6 glioma cells was remarkable compared to non-tumor glial cells (p < 0.05). The releasing rate of hydrophobic cargo from the particles was high (p < 0.05) and reached to maximum, 12 h after targeting C6 cells. The size and drug loading of NPs were found to be controlled by the definite numbers of CCRs and CHUs in APOE. In conclusion, it is suggested that NAPOE NPs can facilitate the controlled delivery of hydrophobic drugs to the malignant C6 glioma cells according to the degree of invasiveness.

Acknowledgements

This paper is a part of the PhD thesis of Nargess Maleklou; PhD student of nanobiotechnology of Shaheed Beheshti Medical University (sbmu). The main theme of the present article has originally been conceived by Nargess Maleklou and it has been designed and set up by her. Experiments were performed at the Cellular and Molecular Biology Research Center in sbmu. We would like to thank Dr Nariman Mosaffa, (specialist in Medical Immunology) for her precise consultation, especially in cell biology.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article. All financial budgets were provided by SBMU.

Supplementary material available online

Supplementary Figure S1 (A-D) and S2 (A-D)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.